... industry and government These groups have raised alarms about the ties between the pharmaceutical industry and health advocacy groups The dominant model in Canada, as elsewhere, however, is the ... safety In the early 1990s, due to government cutbacks in Canada and restrictions in the US, the HPFB and the Food and Drug Administration (FDA) instituted user fees payable by industry In return, the ... “disease awareness” and advocacy Understanding the industry s goals and the infrastructure used to achieve these goals helps bring the ethical issues into clearer focus and, in turn, suggests potential...